VIPERGEN R & D III K/S: Financial statements 2014
CVR: 30355644
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 805,000 and a net result of DKK -12,291,000 compared with DKK -10,661,000 the year before. That is an increase of 0.1% compared with the year before. The profit margin was -1,526.8%. Equity in the 2014 report amounted to DKK 932,000. The solvency ratio was 23%.
- Revenue
- DKK 805,000
- Profit/Loss
- DKK -12,291,000
- Equity
- DKK 932,000
- Total Assets
- DKK 4,047,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 805K | - | -12.3M | 932K | - |
| 2013 | 804K | - | -10.7M | -1.8M | - |
| 2012 | 0 | - | -10.2M | 8.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
VIPERGEN R & D III K/S has published its annual report for 2013. Revenue came to DKK 804,000, and the net result was DKK -10,661,000.
About VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.
